Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Detection of Early-stage Lung Cancer Using Machine Learning and Plasma Metabolomics

NCT04287712 is registered in ClinicalTrials.gov with Peking University People's Hospital as lead sponsor.

NCT NCT04287712
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04287712 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Detection of Early-stage Lung Cancer Using Machine Learning and Plasma Metabolomics
Lead sponsor
Peking University People's Hospital
Phase
Observational
Overall status
Completed
Start date
December 13, 2018
Completion date
May 20, 2020
Enrollment
558 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

early-stage lung cancer